Rapamycin stance and risk–reward thinking

Bob explains why he currently avoids rapamycin, emphasizing individualized risk–benefit analysis.

Play episode from 53:46

chevron_right

Transcript

chevron_right

Transcript

Episode notes

In this episode of the Biohacking Beauty podcast, Bob Troia talks about measurements, and the accuracy of wearables. He also shares his thoughts about the biohacking community in general and how corporations affect it as a whole. Then, he talks about why we should check average measurements instead of day-to-day data. Lastly, Bob talks about frequencies in the body and its effects on the body.

Bob Troia, also known as, Quantified Bob, is a New York City-based technology entrepreneur, biohacker, and self-quantification geek focused on the intersection of data-driven citizen science, health and wellness, human performance, longevity, and personal optimization.

He is the cofounder of Awesome Labs, a health, wellness, and emerging technology studio and the founder of OPTML, a consulting and coaching venture.

What we discussed:

0:00 - Intro

5:51 - Why measurement is important?

7:14 - How Bob started his interest in health?

14:50 - Is relying to quantified data from wearables counterproductive?

17:52 - Bob’s take on the whole biohacking community spectrum

22:00 - How corporations affect the growth of the biohacking community?

25:36- What are Bob’s current interests in self-biohacking?

30:19 - Is the ability to derive accurate measurements the next big thing in health?

32:59 - Why is it important to look at the average measurements?

34:38 - Do combination of different biohacking approaches blunt another one?